🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study is intended to test efficacy, safety and tolerability of two dose...
Status
Completed
Location
Site: 12
Start Date
2004-04-05
Trial ID
NCT01604928
Treatments Being Tested
The primary objective of this study is to evaluate the efficacy of SSR24060...
Status
Completed
Location
Sanofi-Aventis Aministrative Office
Start Date
2007-11
Trial ID
NCT00564226
Treatments Being Tested
This is an investigator-initiated study of safety, efficacy and tolerabilit...
Status
Completed
Location
Deaconess Clinic Gateway Health Center
Start Date
2009-07
Trial ID
NCT00939120
Treatments Being Tested
This study is designed to determine the efficacy of escalating doses of ELB...
Status
Terminated
Location
Private Gynecological Practice
Start Date
2007-02
Trial ID
NCT00439192
Treatments Being Tested
This study will design an alternative urodynamic platform to better evaluat...
Status
Completed
Location
Multiple Locations
Start Date
2008-09-03
Trial ID
NCT00768521
Treatments Being Tested
The purpose of the study is to assess the impact of treatment with tolterod...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2005-03
Trial ID
NCT00143481
Treatments Being Tested
This study is designed to evaluate the safety, tolerability, and efficacy o...
Status
Completed
Location
Coastal Clinical Research Inc.
Start Date
2018-06-14
Trial ID
NCT03583372
Treatments Being Tested
This study is designed to evaluate the safety, tolerability, and efficacy o...
Status
Completed
Location
Central Alabama Research
Start Date
2018-03-26
Trial ID
NCT03492281
Treatments Being Tested
The study is intended to test efficacy, safety and tolerability of two dose...
Status
Completed
Location
Multiple Locations
Start Date
2008-04-28
Trial ID
NCT00689104
Treatments Being Tested
The primary purpose of the trial is to show that tolterodine ER has no effe...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2006-12
Trial ID
NCT00411437
Treatments Being Tested